Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Pharmaceuticals & Biotechnology
Pharmaceuticals
135 Cr
Low Risk
10.4
37.7
0.1
1.9
381.20
121.10
Sales CAGR
Profit CAGR
ROE
ROCE
Speciality Medicines Ltd (SPML) is currently trading at 154.85 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Speciality Medicines Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Speciality Medicines Ltd has traded between a low of ₹121.10 and a high of ₹381.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Speciality Medicines Ltd has a market capitalization of approximately 135.13. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Speciality Medicines Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 10.37 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 135.13 Cr, Speciality Medicines Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Speciality Medicines Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Speciality Medicines Ltd is 10.37. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
2
Neutral
8
Bullish
4
Bearish
13
Neutral
16
Bullish
17
Bearish
11
Neutral
8
Bullish
13
Bearish
2
Neutral
8
Bullish
4
Bearish
2
Neutral
8
Bullish
4
Bearish
11
Neutral
8
Bullish
13
Bearish
11
Neutral
8
Bullish
13
Bearish
11
Neutral
8
Bullish
13
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
132.00 | 145 Cr | 16.18 | 1.52 | 0.00 | 12.38 | 12.15 | 3.93 | ||
29.60 | 138 Cr | 19.18 | 7.78 | 0.00 | 41.95 | 22.81 | 6.97 | ||
105.55 | 136 Cr | 13.24 | 0.97 | 0.77 | 7.69 | 9.73 | 5.99 | ||
154.85 | 135 Cr | 10.37 | 1.90 | 0.00 | 18.31 | 18.42 | 13.68 | ||
87.30 | 134 Cr | 8.95 | 1.39 | 0.00 | 15.51 | 19.06 | 13.51 | ||
64.04 | 130 Cr | 29.79 | 0.70 | 0.00 | 8.06 | 8.98 | 1.68 | ||
100.50 | 127 Cr | 18.28 | 1.96 | 0.00 | 9.36 | 10.75 | 3.79 | ||
| Median: 7 Co. | — | 100.50 | 135 Cr | 16.18 | 1.52 | 0.00 | 12.38 | 12.15 | 5.99 |
AGM/EGM Notice
Speciality Medicines Ltd submitted newspaper publication of the Notice of its 5th AGM. AGM is scheduled for 2026-09-28; notice published in Free Press Gujarat and Lokmitra on 2026-09-04 and filed on 2026-09-05.
AGM/EGM Notice
Speciality Medicines Ltd filed notice for its 5th AGM on 2026-09-28 at 11:00 AM IST via VC/OAVM; e-voting from 2026-09-25 09:00 to 2026-09-27 17:00. Agenda includes adoption of FY2026 audited financials and director reappointment.
Board Meeting
Speciality Medicines Ltd: Board approved Draft Directors' Report for FY2025-26, called 5th AGM on 2026-09-28 at 11:00 AM via VC/OAVM, cut-off date 2026-09-21; appointed NSDL as e-voting agency and a scrutinizer.
